-
1
-
2
Bronchopulmonary Pathology Prevalence Among Premature infants and Estimation of Prophylactic Efficacy and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Premature in...
Published 2020-02-01Subjects: “…pneumococcal conjugate vaccine…”
Get full text
Article -
3
Theoretical Background and Real Results: A Data Review on Vaccine Prevention of Pneumococcal Infection in the World
Published 2018-02-01Subjects: “…pneumococcal conjugate vaccine…”
Get full text
Article -
4
NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
Published 2014-01-01Subjects: Get full text
Article -
5
-
6
Immunological Efficacy and Safety of a New Pneumococcal Polysaccharide Conjugated Thirteen-Valent Vaccine in the Immunization of Adults and Children (Results of Clinical Studies in...
Published 2022-11-01Subjects: “…pneumococcal conjugate vaccine…”
Get full text
Article -
7
Chronicling the Journey of Pneumococcal Conjugate Vaccine Introduction in India
Published 2025-04-01Subjects: “…pneumococcal conjugate vaccine…”
Get full text
Article -
8
Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs
Published 2019-12-01Subjects: Get full text
Article -
9
-
10
Pneumococcal Infection and Vaccination-Related Knowledge, Attitudes and Practices Among Saudi Residents
Published 2025-07-01Subjects: Get full text
Article -
11
Immunological dysfunction of children with severe parapneumonic effusion
Published 2025-06-01Subjects: Get full text
Article -
12
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster d...
Published 2025-12-01Subjects: “…Pneumococcal conjugate vaccines…”
Get full text
Article -
13
A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of...
Published 2025-03-01Subjects: “…pneumococcal conjugate vaccine…”
Get full text
Article -
14
Effectiveness of pneumococcal conjugate 13-valent vaccine against severe pneumonia in Panama: a matched case-control study
Published 2025-07-01Subjects: Get full text
Article -
15
-
16
A case of fulminant pneumococcus meningoencephalitis progressing with white matter involvement despite two doses of conjugated pneumococcus vaccine
Published 2020-12-01Subjects: Get full text
Article -
17
Introduction of the pneumococcal conjugate vaccine in humanitarian and fragile contexts: Perspectives from stakeholders in four African countries
Published 2024-12-01Subjects: Get full text
Article -
18
Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States
Published 2024-11-01Subjects: “…Pneumococcal conjugate vaccine…”
Get full text
Article -
19
Pre-vaccination carriage prevalence of Streptococcus pneumoniae serotypes among internally displaced people in Somaliland: a cross-sectional study
Published 2024-12-01Subjects: Get full text
Article -
20
Invasive Pneumococcal Disease burden and PCV coverage in children under five in Southeast Asia: implications for India
Published 2021-06-01Subjects: Get full text
Article